SARS-CoV-2 antivirals (Bicycle Therapeutics)

N/A

Report date: 2025/01/26 16:18:13

Base Information

Drug NameSARS-CoV-2 antivirals (Bicycle Therapeutics)
Drug Alias NameSARS-CoV-2 spike glycoprotein modulator (Bicycle Therapeutics)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionCoronavirus spike glycoprotein modulators
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBicycle Tx Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBicycle Tx Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A